Kenneth Kalunian Selected Research

Complement System Proteins (Complement)

1/2014

Cell-bound complement activation products in systemic lupus erythematosus: comparison with anti-double-stranded DNA and standard complement measurements.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenneth Kalunian Research Topics

Disease

19	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2024 - 08/2006
6	Lupus Nephritis 03/2024 - 08/2012
5	Rheumatoid Arthritis 01/2022 - 08/2006
4	Infections 01/2024 - 04/2013
3	Herpes Zoster 01/2019 - 11/2016
2	Neoplasms (Cancer) 01/2024 - 01/2019
2	Inflammation (Inflammations) 01/2024 - 08/2006
2	Proteinuria 01/2024 - 01/2019
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2023
1	Seizures (Absence Seizure) 01/2023
1	Cutaneous Lupus Erythematosus 01/2022
1	Myositis Ossificans (Fibrodysplasia Ossificans Progressiva) 01/2022
1	Fatigue 01/2019
1	Tuberculosis (Tuberculoses) 01/2019
1	Chronic Disease (Chronic Diseases) 01/2019
1	Chronic Renal Insufficiency 01/2019
1	Opportunistic Infections (Opportunistic Infection) 01/2019
1	Nasopharyngitis 01/2019
1	Headache (Headaches) 01/2019
1	Retinal Vein Occlusion 01/2019
1	Human Influenza (Influenza) 01/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2014
1	Hyperlipidemias (Hyperlipidemia) 08/2014
1	Hypertension (High Blood Pressure) 08/2014
1	Vitamin D Deficiency 08/2014
1	Sjogren's Syndrome (Sjogren Syndrome) 01/2014
1	Autoimmune Diseases (Autoimmune Disease) 06/2009
1	Injection Site Reaction 12/2007
1	Atherosclerosis 08/2006
1	Giant Cell Arteritis (Horton Disease) 05/2002

Drug/Important Bio-Agent (IBA)

5	Monoclonal AntibodiesIBA 01/2022 - 04/2013
4	InterferonsIBA 01/2021 - 04/2013
3	Immunosuppressive Agents (Immunosuppressants)IBA 01/2024 - 01/2018
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 08/2012
3	AutoantibodiesIBA 01/2023 - 06/2009
3	AntibodiesIBA 01/2016 - 08/2012
2	Adenosine Monophosphate (AMP)IBA 03/2024 - 01/2024
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2024 - 01/2023
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 08/2006
2	GlucocorticoidsIBA 01/2023 - 12/2021
2	Interferon Type IIBA 01/2022 - 01/2017
2	GLPG0634IBA 01/2022 - 01/2019
2	AntigensIBA 01/2022 - 01/2014
2	CreatinineIBA 08/2020 - 01/2019
2	C-Reactive ProteinIBA 01/2019 - 08/2014
2	sifalimumabIBA 11/2016 - 04/2013
2	Complement C3 (C3 Complement)IBA 01/2016 - 01/2014
2	epratuzumabIBA 01/2014 - 07/2013
1	TeratogensIBA 01/2024
1	Antiphospholipid AntibodiesIBA 01/2023
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2023
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022
1	Codon (Codons)IBA 01/2022
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2021
1	belimumabIBA 01/2021
1	Antirheumatic Agents (DMARD)IBA 01/2019
1	Nucleosomes (Nucleosome)IBA 12/2017
1	anifrolumabIBA 01/2017
1	hydroxide ionIBA 08/2014
1	25-hydroxyvitamin DIBA 08/2014
1	Complement System Proteins (Complement)IBA 01/2014
1	complement C4dIBA 01/2014
1	Antinuclear AntibodiesIBA 08/2012
1	Immunoglobulins (Immunoglobulin)IBA 12/2007
1	TACI receptor-IgG Fc fragment fusion proteinIBA 12/2007
1	oxidized low density lipoproteinIBA 08/2006
1	HDL LipoproteinsIBA 08/2006
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2002
1	Methotrexate (Mexate)FDA LinkGeneric 05/2002

Therapy/Procedure

3	Therapeutics 01/2024 - 01/2017
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2019